Last reviewed · How we verify
fentanyl and Remimazolam
At a glance
| Generic name | fentanyl and Remimazolam |
|---|---|
| Sponsor | Indiana University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Use of Remimazolam and Fentanyl for Procedural Sedation in Patients Undergoing Dental Extraction (PHASE4)
- Remimazolam for Bronchoscopy in High-Risk Patients (PHASE4)
- A Randomized, Controlled Clinical Trial Comparing Remimazolam Besylate Combined With Alfentanil Versus Propofol Combined With Alfentanil for Anesthesia in Thoracic Surgery (PHASE4)
- Varied Remimazolam Dosages for Pediatric Endoscopy (NA)
- Deep Sedation With Pre-emptive Endotracheal Intubation for Advanced Bronchoscopy Procedures
- Comparison of Postoperative Quality of Recovery by Anesthetic Method in Patients Undergoing Shoulder Arthroscopy (NA)
- Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression (PHASE4)
- Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |